Review



shrna control  (Addgene inc)


Bioz Verified Symbol Addgene inc is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    Addgene inc shrna control
    <t>Pathological</t> <t>TDP-43</t> elicits glycolytic impairment in cells. a , b Agilent seahorse glycolytic stress test was performed on n = 3 independent biological repeats. Glycolysis and Glycolytic Capacity were measured according to manufacturer’s protocol. ECAR values were normalized to total protein then plotted against time. Individual glycolysis and glycolytic capacity values were normalized to total protein level then to individual control from each biological repeat. a Stable HEK293 cells were overexpressed with either YFP (control), TDP-43 WT or TDP-43 ΔNLS . Data were analyzed by one-way ANOVA followed by post hoc Tukey’s test. b TDP-43 G298S patient iPSC and control iPSC were differentiated into motor neurons with our established protocol. On day 26 following differentiation, cells were treated with MG-132 (1 μM) for 24 h. Data were analyzed by Student’s t-test. c YFP (control), TDP-43 WT or TDP-43 ΔNLS stable cells were transiently transfected with various glycolysis shRNAs. Cell viability was measured via MTT assay. Decreased cell viability in all TDP-43 WT and TDP-43 ΔNLS with various glycolysis <t>shRNA</t> (n = 3). Data were analyzed by one-way ANOVA followed by post hoc Tukey’s test. All data are mean ± SE
    Shrna Control, supplied by Addgene inc, used in various techniques. Bioz Stars score: 96/100, based on 1557 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/plko%2E1+control+shrna/pLKO%2E1+puro+(Plasmid+%238453)/pmc12992470-33-33-35
    Average 96 stars, based on 1557 article reviews
    shrna control - by Bioz Stars, 2026-09
    96/100 stars

    Images

    1) Product Images from "TDP-43 impairs glycolysis by sequestering hexokinase 1 in amyotrophic lateral sclerosis"

    Article Title: TDP-43 impairs glycolysis by sequestering hexokinase 1 in amyotrophic lateral sclerosis

    Journal: Acta Neuropathologica

    doi: 10.1007/s00401-026-02996-6

    Pathological TDP-43 elicits glycolytic impairment in cells. a , b Agilent seahorse glycolytic stress test was performed on n = 3 independent biological repeats. Glycolysis and Glycolytic Capacity were measured according to manufacturer’s protocol. ECAR values were normalized to total protein then plotted against time. Individual glycolysis and glycolytic capacity values were normalized to total protein level then to individual control from each biological repeat. a Stable HEK293 cells were overexpressed with either YFP (control), TDP-43 WT or TDP-43 ΔNLS . Data were analyzed by one-way ANOVA followed by post hoc Tukey’s test. b TDP-43 G298S patient iPSC and control iPSC were differentiated into motor neurons with our established protocol. On day 26 following differentiation, cells were treated with MG-132 (1 μM) for 24 h. Data were analyzed by Student’s t-test. c YFP (control), TDP-43 WT or TDP-43 ΔNLS stable cells were transiently transfected with various glycolysis shRNAs. Cell viability was measured via MTT assay. Decreased cell viability in all TDP-43 WT and TDP-43 ΔNLS with various glycolysis shRNA (n = 3). Data were analyzed by one-way ANOVA followed by post hoc Tukey’s test. All data are mean ± SE
    Figure Legend Snippet: Pathological TDP-43 elicits glycolytic impairment in cells. a , b Agilent seahorse glycolytic stress test was performed on n = 3 independent biological repeats. Glycolysis and Glycolytic Capacity were measured according to manufacturer’s protocol. ECAR values were normalized to total protein then plotted against time. Individual glycolysis and glycolytic capacity values were normalized to total protein level then to individual control from each biological repeat. a Stable HEK293 cells were overexpressed with either YFP (control), TDP-43 WT or TDP-43 ΔNLS . Data were analyzed by one-way ANOVA followed by post hoc Tukey’s test. b TDP-43 G298S patient iPSC and control iPSC were differentiated into motor neurons with our established protocol. On day 26 following differentiation, cells were treated with MG-132 (1 μM) for 24 h. Data were analyzed by Student’s t-test. c YFP (control), TDP-43 WT or TDP-43 ΔNLS stable cells were transiently transfected with various glycolysis shRNAs. Cell viability was measured via MTT assay. Decreased cell viability in all TDP-43 WT and TDP-43 ΔNLS with various glycolysis shRNA (n = 3). Data were analyzed by one-way ANOVA followed by post hoc Tukey’s test. All data are mean ± SE

    Techniques Used: Control, Transfection, MTT Assay, shRNA

    Related Articles

    Plasmid Preparation:

    Article Title: ΔNp63α drives serine synthesis to promote carboplatin resistance in NSCLC
    Article Snippet: The short hairpin RNAs (shRNAs) targeting human p63 or ATF4 was generated by inserting specific oligoes into a pLKO.1-puromycin lentiviral vector (10878, Addgene, Cambridge, MA, USA). .. The pLKO.1-scramble vector (#1864, Addgene) was used as a negative control vector and contained a scrambled shRNA (shC). ..

    Article Title: Epigenetic Buffering of Proteotoxic Stress by EHMT2 Enables Meningioma Growth
    Article Snippet: 219 Ac ce pte d M an us cri pt D ow nloaded from https://academ ic.oup.com /noa/advance-article/doi/10.1093/noajnl/vdag037/8483041 by M aria M estriner user on 07 M arch 2026 Manuscript number NOA-D-25-00449R2 10 Immunostained bands were detected using chemiluminescence (Pierce ECL Western 220 Blotting Substrate, 32209, ThermoFisher Scientific; SuperSignal West Pico PLUS 221 Chemiluminescent Substrate, 34577, ThermoFisher Scientific), and images were 222 obtained using either a KODAK Image Station 4000 System or a Li-Cor Odyssey M 223 Imaging System. .. 224 225 Lentivirus production and generation of ATF4 and CHOP knockdown and SirT1 226 overexpression meningioma cell lines 227 Lentiviral small hairpin RNA (shRNA) vectors for ATF4 (TRCN0000013573; 228 TRCN0000013575) and CHOP (TRCN0000007263; TRCN0000364393) as well as 229 MISSION® ORF SirT1 overexpression (TRCN0000487877) and MISSION® TRC3 ORF 230 GFP control (ORFGFP) were purchased from Sigma-Adrich. pLKO.1 puro (Plasmid 231 #8453) was acquired from Addgene. ..

    Article Title: TDP-43 impairs glycolysis by sequestering hexokinase 1 in amyotrophic lateral sclerosis.
    Article Snippet: The secondary HRP-conjugated antibodies Goat anti-mouse HRP (#31430; WB 1:5000) and goat antirabbit HRP (#31460; WB 1:5000) were purchased from Thermo Fisher Scientific. .. The following constructs pcDNA3.2-YFP (addgene #84910) , pcDNA3.2 -TDP-43 W T-YFP (human) (addgene #84911), pcDNA3.2-TDP-43ΔNLS-YFP (human) (addgene #84912), pLD-puro-Cc-TARDBPA315T_VA Plasmid (human TDP-43 A315T) (addgene #141329), pLD-puro-Cc-TARDBP-WT_VA Plasmid (human TDP-43 WT) (addgene #141327), and shRNA control (addgene: #8453) were purchased from addgene. .. The following shRNA vectors HK1 (TRCN0000037656), GPI (TRCN0000049149), PFKM (TRCN0000037772), ALDOA (TRCN0000052504), TPI1 (TRCN0000289672), PGK1 (TRCN0000006180), PGAM1 (TRCN0000353685), ENO1 (TRCN0000029326), PKM (TRCN0000196588), LDHA (TRCN0000164922), and GAPDH (TRCN0000025828) were purchased from Sigma-Aldrich.

    Article Title: ΔNp63α drives serine synthesis to promote carboplatin resistance in NSCLC.
    Article Snippet: The short hairpin RNAs (shRNAs) targeting human p63 or ATF4 was generated by inserting specific oligoes into a pLKO.1-puromycin lentiviral vector (10878, Addgene, Cambridge, MA, USA). .. The pLKO.1-scramble vector (#1864, Addgene) was used as a negative control vector and contained a scrambled shRNA (shC). ..

    Article Title: TDP-43 impairs glycolysis by sequestering hexokinase 1 in amyotrophic lateral sclerosis
    Article Snippet: The secondary HRP-conjugated antibodies Goat anti-mouse HRP (#31430; WB 1:5000) and goat anti-rabbit HRP (#31460; WB 1:5000) were purchased from Thermo Fisher Scientific. .. The following constructs pcDNA3.2-YFP (addgene #84910), pcDNA3.2-TDP-43 WT -YFP (human) (addgene #84911), pcDNA3.2-TDP-43 ΔNLS -YFP (human) (addgene #84912), pLD-puro-Cc-TARDBP-A315T_VA Plasmid (human TDP-43 A315T) (addgene #141329), pLD-puro-Cc-TARDBP-WT_VA Plasmid (human TDP-43 WT) (addgene #141327), and shRNA control (addgene: #8453) were purchased from addgene. .. The following shRNA vectors HK1 (TRCN0000037656), GPI (TRCN0000049149), PFKM (TRCN0000037772), ALDOA (TRCN0000052504), TPI1 (TRCN0000289672), PGK1 (TRCN0000006180), PGAM1 (TRCN0000353685), ENO1 (TRCN0000029326), PKM (TRCN0000196588), LDHA (TRCN0000164922), and GAPDH (TRCN0000025828) were purchased from Sigma-Aldrich.

    Article Title: Modulation of the Receptor Tyrosine Kinase TIE2/ Tek Pathway by NRF2 Activation in Neurovascular Endothelial Cells.
    Article Snippet: Lentiviruses were produced in HEK293T cells co-transfected with 6 μg of pSPAX2 packaging plasmid (12260, Addgene, Watertown, MA, USA), 6 μg of VSV–G envelope protein plasmid pMD2G (12259, Addgene), and 10 μg of the corresponding lentiviral vector, an empty vector (shCtrl) or with the corresponding shRNA plasmids and packaging vectors, or the pLENTI-PURO empty vector control. .. Lentiviral vector pLKO.1 shRNA control (shCtrl) (Addgene Plasmid #10879) was purchased from Addgene; pLKO-puro shNRF2 (NM_010902) was purchased from Sigma-Aldrich. ..

    Negative Control:

    Article Title: ΔNp63α drives serine synthesis to promote carboplatin resistance in NSCLC
    Article Snippet: The short hairpin RNAs (shRNAs) targeting human p63 or ATF4 was generated by inserting specific oligoes into a pLKO.1-puromycin lentiviral vector (10878, Addgene, Cambridge, MA, USA). .. The pLKO.1-scramble vector (#1864, Addgene) was used as a negative control vector and contained a scrambled shRNA (shC). ..

    Article Title: ΔNp63α drives serine synthesis to promote carboplatin resistance in NSCLC.
    Article Snippet: The short hairpin RNAs (shRNAs) targeting human p63 or ATF4 was generated by inserting specific oligoes into a pLKO.1-puromycin lentiviral vector (10878, Addgene, Cambridge, MA, USA). .. The pLKO.1-scramble vector (#1864, Addgene) was used as a negative control vector and contained a scrambled shRNA (shC). ..

    shRNA:

    Article Title: ΔNp63α drives serine synthesis to promote carboplatin resistance in NSCLC
    Article Snippet: The short hairpin RNAs (shRNAs) targeting human p63 or ATF4 was generated by inserting specific oligoes into a pLKO.1-puromycin lentiviral vector (10878, Addgene, Cambridge, MA, USA). .. The pLKO.1-scramble vector (#1864, Addgene) was used as a negative control vector and contained a scrambled shRNA (shC). ..

    Article Title: Epigenetic Buffering of Proteotoxic Stress by EHMT2 Enables Meningioma Growth
    Article Snippet: 219 Ac ce pte d M an us cri pt D ow nloaded from https://academ ic.oup.com /noa/advance-article/doi/10.1093/noajnl/vdag037/8483041 by M aria M estriner user on 07 M arch 2026 Manuscript number NOA-D-25-00449R2 10 Immunostained bands were detected using chemiluminescence (Pierce ECL Western 220 Blotting Substrate, 32209, ThermoFisher Scientific; SuperSignal West Pico PLUS 221 Chemiluminescent Substrate, 34577, ThermoFisher Scientific), and images were 222 obtained using either a KODAK Image Station 4000 System or a Li-Cor Odyssey M 223 Imaging System. .. 224 225 Lentivirus production and generation of ATF4 and CHOP knockdown and SirT1 226 overexpression meningioma cell lines 227 Lentiviral small hairpin RNA (shRNA) vectors for ATF4 (TRCN0000013573; 228 TRCN0000013575) and CHOP (TRCN0000007263; TRCN0000364393) as well as 229 MISSION® ORF SirT1 overexpression (TRCN0000487877) and MISSION® TRC3 ORF 230 GFP control (ORFGFP) were purchased from Sigma-Adrich. pLKO.1 puro (Plasmid 231 #8453) was acquired from Addgene. ..

    Article Title: TDP-43 impairs glycolysis by sequestering hexokinase 1 in amyotrophic lateral sclerosis.
    Article Snippet: The secondary HRP-conjugated antibodies Goat anti-mouse HRP (#31430; WB 1:5000) and goat antirabbit HRP (#31460; WB 1:5000) were purchased from Thermo Fisher Scientific. .. The following constructs pcDNA3.2-YFP (addgene #84910) , pcDNA3.2 -TDP-43 W T-YFP (human) (addgene #84911), pcDNA3.2-TDP-43ΔNLS-YFP (human) (addgene #84912), pLD-puro-Cc-TARDBPA315T_VA Plasmid (human TDP-43 A315T) (addgene #141329), pLD-puro-Cc-TARDBP-WT_VA Plasmid (human TDP-43 WT) (addgene #141327), and shRNA control (addgene: #8453) were purchased from addgene. .. The following shRNA vectors HK1 (TRCN0000037656), GPI (TRCN0000049149), PFKM (TRCN0000037772), ALDOA (TRCN0000052504), TPI1 (TRCN0000289672), PGK1 (TRCN0000006180), PGAM1 (TRCN0000353685), ENO1 (TRCN0000029326), PKM (TRCN0000196588), LDHA (TRCN0000164922), and GAPDH (TRCN0000025828) were purchased from Sigma-Aldrich.

    Article Title: ΔNp63α drives serine synthesis to promote carboplatin resistance in NSCLC.
    Article Snippet: The short hairpin RNAs (shRNAs) targeting human p63 or ATF4 was generated by inserting specific oligoes into a pLKO.1-puromycin lentiviral vector (10878, Addgene, Cambridge, MA, USA). .. The pLKO.1-scramble vector (#1864, Addgene) was used as a negative control vector and contained a scrambled shRNA (shC). ..

    Article Title: TDP-43 impairs glycolysis by sequestering hexokinase 1 in amyotrophic lateral sclerosis
    Article Snippet: The secondary HRP-conjugated antibodies Goat anti-mouse HRP (#31430; WB 1:5000) and goat anti-rabbit HRP (#31460; WB 1:5000) were purchased from Thermo Fisher Scientific. .. The following constructs pcDNA3.2-YFP (addgene #84910), pcDNA3.2-TDP-43 WT -YFP (human) (addgene #84911), pcDNA3.2-TDP-43 ΔNLS -YFP (human) (addgene #84912), pLD-puro-Cc-TARDBP-A315T_VA Plasmid (human TDP-43 A315T) (addgene #141329), pLD-puro-Cc-TARDBP-WT_VA Plasmid (human TDP-43 WT) (addgene #141327), and shRNA control (addgene: #8453) were purchased from addgene. .. The following shRNA vectors HK1 (TRCN0000037656), GPI (TRCN0000049149), PFKM (TRCN0000037772), ALDOA (TRCN0000052504), TPI1 (TRCN0000289672), PGK1 (TRCN0000006180), PGAM1 (TRCN0000353685), ENO1 (TRCN0000029326), PKM (TRCN0000196588), LDHA (TRCN0000164922), and GAPDH (TRCN0000025828) were purchased from Sigma-Aldrich.

    Article Title: Modulation of the Receptor Tyrosine Kinase TIE2/ Tek Pathway by NRF2 Activation in Neurovascular Endothelial Cells.
    Article Snippet: Lentiviruses were produced in HEK293T cells co-transfected with 6 μg of pSPAX2 packaging plasmid (12260, Addgene, Watertown, MA, USA), 6 μg of VSV–G envelope protein plasmid pMD2G (12259, Addgene), and 10 μg of the corresponding lentiviral vector, an empty vector (shCtrl) or with the corresponding shRNA plasmids and packaging vectors, or the pLENTI-PURO empty vector control. .. Lentiviral vector pLKO.1 shRNA control (shCtrl) (Addgene Plasmid #10879) was purchased from Addgene; pLKO-puro shNRF2 (NM_010902) was purchased from Sigma-Aldrich. ..

    other:

    Article Title: DCPS modulates TDP-43-linked neurodegeneration through P-body-mediated RNA decay
    Article Snippet: Please refer to Table S5 for more details N/A ARTR-seq adapter-RT primer(5 ′ -AGACGTGTG CTCTTCCGATCTNNNNNNNNNN-3 ′ ) Xiao et al. 60 N/A ARTR-seq 3 ′ cDNA adapter (5 ′ Phos-8N-AGAT CGGAAGAGGTCGTGT-3 ′ SpC3) Xiao et al. 60 N/A Recombinant DNA Plasmid: pMDLg/pRRE Dull et al. 81 RRID: Addgene_12251 Plasmid: pRSV-Rev Dull et al. 81 RRID: Addgene_12253 Plasmid: pMD2.G A gift from Didier Trono RRID: Addgene_12259 Plasmid: pLG1-control sgRNA Tian et al. 41 N/A Plasmid: pLG1-TDP-43 sgRNA This paper N/A Plasmid: pLG1-DCPS sgRNA 1 This paper N/A Plasmid: pLG1-DCPS sgRNA 2 This paper N/A Plasmid: pLKO.1-control shRNA A gift from David Root 82 RRID: Addgene_10879 Plasmid: pLKO.1-TDP-43 shRNA This paper N/A Plasmid: pLKO.1-DCPS shRNA #1 This paper N/A Plasmid: pLKO.1-DCPS shRNA #2 This paper N/A Plasmid: Lenti-GFP-puro Zhang et al. 45 N/A Plasmid: Lenti-FLAG-TDP-43 dNLS This paper N/A Plasmid: Lenti- FLAG-TDP-43 WT -APEX2 This paper N/A Plasmid: Lenti- FLAG-TDP-43 dNLS -APEX2 This paper N/A Plasmid: pEGFP-N1-TDP-43 Cheng et al. 83 N/A Plasmid: pcDNA3.1-FLAG-TDP-43 dNLS This paper N/A Plasmid: pT7-EGFP-C1-HsDCP2 Tritschler et al. 84 RRID: Addgene_25031 (Continued on next page) e4 Neuron 114, 1–16.e1–e12, June 3, 2026

    Knockdown:

    Article Title: Epigenetic Buffering of Proteotoxic Stress by EHMT2 Enables Meningioma Growth
    Article Snippet: 219 Ac ce pte d M an us cri pt D ow nloaded from https://academ ic.oup.com /noa/advance-article/doi/10.1093/noajnl/vdag037/8483041 by M aria M estriner user on 07 M arch 2026 Manuscript number NOA-D-25-00449R2 10 Immunostained bands were detected using chemiluminescence (Pierce ECL Western 220 Blotting Substrate, 32209, ThermoFisher Scientific; SuperSignal West Pico PLUS 221 Chemiluminescent Substrate, 34577, ThermoFisher Scientific), and images were 222 obtained using either a KODAK Image Station 4000 System or a Li-Cor Odyssey M 223 Imaging System. .. 224 225 Lentivirus production and generation of ATF4 and CHOP knockdown and SirT1 226 overexpression meningioma cell lines 227 Lentiviral small hairpin RNA (shRNA) vectors for ATF4 (TRCN0000013573; 228 TRCN0000013575) and CHOP (TRCN0000007263; TRCN0000364393) as well as 229 MISSION® ORF SirT1 overexpression (TRCN0000487877) and MISSION® TRC3 ORF 230 GFP control (ORFGFP) were purchased from Sigma-Adrich. pLKO.1 puro (Plasmid 231 #8453) was acquired from Addgene. ..

    Over Expression:

    Article Title: Epigenetic Buffering of Proteotoxic Stress by EHMT2 Enables Meningioma Growth
    Article Snippet: 219 Ac ce pte d M an us cri pt D ow nloaded from https://academ ic.oup.com /noa/advance-article/doi/10.1093/noajnl/vdag037/8483041 by M aria M estriner user on 07 M arch 2026 Manuscript number NOA-D-25-00449R2 10 Immunostained bands were detected using chemiluminescence (Pierce ECL Western 220 Blotting Substrate, 32209, ThermoFisher Scientific; SuperSignal West Pico PLUS 221 Chemiluminescent Substrate, 34577, ThermoFisher Scientific), and images were 222 obtained using either a KODAK Image Station 4000 System or a Li-Cor Odyssey M 223 Imaging System. .. 224 225 Lentivirus production and generation of ATF4 and CHOP knockdown and SirT1 226 overexpression meningioma cell lines 227 Lentiviral small hairpin RNA (shRNA) vectors for ATF4 (TRCN0000013573; 228 TRCN0000013575) and CHOP (TRCN0000007263; TRCN0000364393) as well as 229 MISSION® ORF SirT1 overexpression (TRCN0000487877) and MISSION® TRC3 ORF 230 GFP control (ORFGFP) were purchased from Sigma-Adrich. pLKO.1 puro (Plasmid 231 #8453) was acquired from Addgene. ..

    Control:

    Article Title: Epigenetic Buffering of Proteotoxic Stress by EHMT2 Enables Meningioma Growth
    Article Snippet: 219 Ac ce pte d M an us cri pt D ow nloaded from https://academ ic.oup.com /noa/advance-article/doi/10.1093/noajnl/vdag037/8483041 by M aria M estriner user on 07 M arch 2026 Manuscript number NOA-D-25-00449R2 10 Immunostained bands were detected using chemiluminescence (Pierce ECL Western 220 Blotting Substrate, 32209, ThermoFisher Scientific; SuperSignal West Pico PLUS 221 Chemiluminescent Substrate, 34577, ThermoFisher Scientific), and images were 222 obtained using either a KODAK Image Station 4000 System or a Li-Cor Odyssey M 223 Imaging System. .. 224 225 Lentivirus production and generation of ATF4 and CHOP knockdown and SirT1 226 overexpression meningioma cell lines 227 Lentiviral small hairpin RNA (shRNA) vectors for ATF4 (TRCN0000013573; 228 TRCN0000013575) and CHOP (TRCN0000007263; TRCN0000364393) as well as 229 MISSION® ORF SirT1 overexpression (TRCN0000487877) and MISSION® TRC3 ORF 230 GFP control (ORFGFP) were purchased from Sigma-Adrich. pLKO.1 puro (Plasmid 231 #8453) was acquired from Addgene. ..

    Article Title: TDP-43 impairs glycolysis by sequestering hexokinase 1 in amyotrophic lateral sclerosis.
    Article Snippet: The secondary HRP-conjugated antibodies Goat anti-mouse HRP (#31430; WB 1:5000) and goat antirabbit HRP (#31460; WB 1:5000) were purchased from Thermo Fisher Scientific. .. The following constructs pcDNA3.2-YFP (addgene #84910) , pcDNA3.2 -TDP-43 W T-YFP (human) (addgene #84911), pcDNA3.2-TDP-43ΔNLS-YFP (human) (addgene #84912), pLD-puro-Cc-TARDBPA315T_VA Plasmid (human TDP-43 A315T) (addgene #141329), pLD-puro-Cc-TARDBP-WT_VA Plasmid (human TDP-43 WT) (addgene #141327), and shRNA control (addgene: #8453) were purchased from addgene. .. The following shRNA vectors HK1 (TRCN0000037656), GPI (TRCN0000049149), PFKM (TRCN0000037772), ALDOA (TRCN0000052504), TPI1 (TRCN0000289672), PGK1 (TRCN0000006180), PGAM1 (TRCN0000353685), ENO1 (TRCN0000029326), PKM (TRCN0000196588), LDHA (TRCN0000164922), and GAPDH (TRCN0000025828) were purchased from Sigma-Aldrich.

    Article Title: TDP-43 impairs glycolysis by sequestering hexokinase 1 in amyotrophic lateral sclerosis
    Article Snippet: The secondary HRP-conjugated antibodies Goat anti-mouse HRP (#31430; WB 1:5000) and goat anti-rabbit HRP (#31460; WB 1:5000) were purchased from Thermo Fisher Scientific. .. The following constructs pcDNA3.2-YFP (addgene #84910), pcDNA3.2-TDP-43 WT -YFP (human) (addgene #84911), pcDNA3.2-TDP-43 ΔNLS -YFP (human) (addgene #84912), pLD-puro-Cc-TARDBP-A315T_VA Plasmid (human TDP-43 A315T) (addgene #141329), pLD-puro-Cc-TARDBP-WT_VA Plasmid (human TDP-43 WT) (addgene #141327), and shRNA control (addgene: #8453) were purchased from addgene. .. The following shRNA vectors HK1 (TRCN0000037656), GPI (TRCN0000049149), PFKM (TRCN0000037772), ALDOA (TRCN0000052504), TPI1 (TRCN0000289672), PGK1 (TRCN0000006180), PGAM1 (TRCN0000353685), ENO1 (TRCN0000029326), PKM (TRCN0000196588), LDHA (TRCN0000164922), and GAPDH (TRCN0000025828) were purchased from Sigma-Aldrich.

    Article Title: Modulation of the Receptor Tyrosine Kinase TIE2/ Tek Pathway by NRF2 Activation in Neurovascular Endothelial Cells.
    Article Snippet: Lentiviruses were produced in HEK293T cells co-transfected with 6 μg of pSPAX2 packaging plasmid (12260, Addgene, Watertown, MA, USA), 6 μg of VSV–G envelope protein plasmid pMD2G (12259, Addgene), and 10 μg of the corresponding lentiviral vector, an empty vector (shCtrl) or with the corresponding shRNA plasmids and packaging vectors, or the pLENTI-PURO empty vector control. .. Lentiviral vector pLKO.1 shRNA control (shCtrl) (Addgene Plasmid #10879) was purchased from Addgene; pLKO-puro shNRF2 (NM_010902) was purchased from Sigma-Aldrich. ..

    Construct:

    Article Title: TDP-43 impairs glycolysis by sequestering hexokinase 1 in amyotrophic lateral sclerosis.
    Article Snippet: The secondary HRP-conjugated antibodies Goat anti-mouse HRP (#31430; WB 1:5000) and goat antirabbit HRP (#31460; WB 1:5000) were purchased from Thermo Fisher Scientific. .. The following constructs pcDNA3.2-YFP (addgene #84910) , pcDNA3.2 -TDP-43 W T-YFP (human) (addgene #84911), pcDNA3.2-TDP-43ΔNLS-YFP (human) (addgene #84912), pLD-puro-Cc-TARDBPA315T_VA Plasmid (human TDP-43 A315T) (addgene #141329), pLD-puro-Cc-TARDBP-WT_VA Plasmid (human TDP-43 WT) (addgene #141327), and shRNA control (addgene: #8453) were purchased from addgene. .. The following shRNA vectors HK1 (TRCN0000037656), GPI (TRCN0000049149), PFKM (TRCN0000037772), ALDOA (TRCN0000052504), TPI1 (TRCN0000289672), PGK1 (TRCN0000006180), PGAM1 (TRCN0000353685), ENO1 (TRCN0000029326), PKM (TRCN0000196588), LDHA (TRCN0000164922), and GAPDH (TRCN0000025828) were purchased from Sigma-Aldrich.

    Article Title: TDP-43 impairs glycolysis by sequestering hexokinase 1 in amyotrophic lateral sclerosis
    Article Snippet: The secondary HRP-conjugated antibodies Goat anti-mouse HRP (#31430; WB 1:5000) and goat anti-rabbit HRP (#31460; WB 1:5000) were purchased from Thermo Fisher Scientific. .. The following constructs pcDNA3.2-YFP (addgene #84910), pcDNA3.2-TDP-43 WT -YFP (human) (addgene #84911), pcDNA3.2-TDP-43 ΔNLS -YFP (human) (addgene #84912), pLD-puro-Cc-TARDBP-A315T_VA Plasmid (human TDP-43 A315T) (addgene #141329), pLD-puro-Cc-TARDBP-WT_VA Plasmid (human TDP-43 WT) (addgene #141327), and shRNA control (addgene: #8453) were purchased from addgene. .. The following shRNA vectors HK1 (TRCN0000037656), GPI (TRCN0000049149), PFKM (TRCN0000037772), ALDOA (TRCN0000052504), TPI1 (TRCN0000289672), PGK1 (TRCN0000006180), PGAM1 (TRCN0000353685), ENO1 (TRCN0000029326), PKM (TRCN0000196588), LDHA (TRCN0000164922), and GAPDH (TRCN0000025828) were purchased from Sigma-Aldrich.



    Similar Products

    96
    Addgene inc shrna control
    <t>Pathological</t> <t>TDP-43</t> elicits glycolytic impairment in cells. a , b Agilent seahorse glycolytic stress test was performed on n = 3 independent biological repeats. Glycolysis and Glycolytic Capacity were measured according to manufacturer’s protocol. ECAR values were normalized to total protein then plotted against time. Individual glycolysis and glycolytic capacity values were normalized to total protein level then to individual control from each biological repeat. a Stable HEK293 cells were overexpressed with either YFP (control), TDP-43 WT or TDP-43 ΔNLS . Data were analyzed by one-way ANOVA followed by post hoc Tukey’s test. b TDP-43 G298S patient iPSC and control iPSC were differentiated into motor neurons with our established protocol. On day 26 following differentiation, cells were treated with MG-132 (1 μM) for 24 h. Data were analyzed by Student’s t-test. c YFP (control), TDP-43 WT or TDP-43 ΔNLS stable cells were transiently transfected with various glycolysis shRNAs. Cell viability was measured via MTT assay. Decreased cell viability in all TDP-43 WT and TDP-43 ΔNLS with various glycolysis <t>shRNA</t> (n = 3). Data were analyzed by one-way ANOVA followed by post hoc Tukey’s test. All data are mean ± SE
    Shrna Control, supplied by Addgene inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/plko%2E1+control+shrna/pLKO%2E1+puro+(Plasmid+%238453)/pmc12992470-33-33-35
    Average 96 stars, based on 1 article reviews
    shrna control - by Bioz Stars, 2026-09
    96/100 stars
      Buy from Supplier

    96
    Addgene inc plko 1 control shrna
    <t>Pathological</t> <t>TDP-43</t> elicits glycolytic impairment in cells. a , b Agilent seahorse glycolytic stress test was performed on n = 3 independent biological repeats. Glycolysis and Glycolytic Capacity were measured according to manufacturer’s protocol. ECAR values were normalized to total protein then plotted against time. Individual glycolysis and glycolytic capacity values were normalized to total protein level then to individual control from each biological repeat. a Stable HEK293 cells were overexpressed with either YFP (control), TDP-43 WT or TDP-43 ΔNLS . Data were analyzed by one-way ANOVA followed by post hoc Tukey’s test. b TDP-43 G298S patient iPSC and control iPSC were differentiated into motor neurons with our established protocol. On day 26 following differentiation, cells were treated with MG-132 (1 μM) for 24 h. Data were analyzed by Student’s t-test. c YFP (control), TDP-43 WT or TDP-43 ΔNLS stable cells were transiently transfected with various glycolysis shRNAs. Cell viability was measured via MTT assay. Decreased cell viability in all TDP-43 WT and TDP-43 ΔNLS with various glycolysis <t>shRNA</t> (n = 3). Data were analyzed by one-way ANOVA followed by post hoc Tukey’s test. All data are mean ± SE
    Plko 1 Control Shrna, supplied by Addgene inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/plko%2E1+control+shrna/pLKO%2E1+-+TRC+control+(Plasmid+%2310879)/10__1016_slash_j__neuron__2026__01__018-263-94-103
    Average 96 stars, based on 1 article reviews
    plko 1 control shrna - by Bioz Stars, 2026-09
    96/100 stars
      Buy from Supplier

    96
    Addgene inc lentiviral vector plko 1 shrna control shctrl
    <t>Pathological</t> <t>TDP-43</t> elicits glycolytic impairment in cells. a , b Agilent seahorse glycolytic stress test was performed on n = 3 independent biological repeats. Glycolysis and Glycolytic Capacity were measured according to manufacturer’s protocol. ECAR values were normalized to total protein then plotted against time. Individual glycolysis and glycolytic capacity values were normalized to total protein level then to individual control from each biological repeat. a Stable HEK293 cells were overexpressed with either YFP (control), TDP-43 WT or TDP-43 ΔNLS . Data were analyzed by one-way ANOVA followed by post hoc Tukey’s test. b TDP-43 G298S patient iPSC and control iPSC were differentiated into motor neurons with our established protocol. On day 26 following differentiation, cells were treated with MG-132 (1 μM) for 24 h. Data were analyzed by Student’s t-test. c YFP (control), TDP-43 WT or TDP-43 ΔNLS stable cells were transiently transfected with various glycolysis shRNAs. Cell viability was measured via MTT assay. Decreased cell viability in all TDP-43 WT and TDP-43 ΔNLS with various glycolysis <t>shRNA</t> (n = 3). Data were analyzed by one-way ANOVA followed by post hoc Tukey’s test. All data are mean ± SE
    Lentiviral Vector Plko 1 Shrna Control Shctrl, supplied by Addgene inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/plko%2E1+control+shrna/pLKO%2E1+-+TRC+control+(Plasmid+%2310879)/pm41596422-229-0-6
    Average 96 stars, based on 1 article reviews
    lentiviral vector plko 1 shrna control shctrl - by Bioz Stars, 2026-09
    96/100 stars
      Buy from Supplier

    93
    Addgene inc non targeting control plko 1 puro plasmid dna ntc
    <t>Pathological</t> <t>TDP-43</t> elicits glycolytic impairment in cells. a , b Agilent seahorse glycolytic stress test was performed on n = 3 independent biological repeats. Glycolysis and Glycolytic Capacity were measured according to manufacturer’s protocol. ECAR values were normalized to total protein then plotted against time. Individual glycolysis and glycolytic capacity values were normalized to total protein level then to individual control from each biological repeat. a Stable HEK293 cells were overexpressed with either YFP (control), TDP-43 WT or TDP-43 ΔNLS . Data were analyzed by one-way ANOVA followed by post hoc Tukey’s test. b TDP-43 G298S patient iPSC and control iPSC were differentiated into motor neurons with our established protocol. On day 26 following differentiation, cells were treated with MG-132 (1 μM) for 24 h. Data were analyzed by Student’s t-test. c YFP (control), TDP-43 WT or TDP-43 ΔNLS stable cells were transiently transfected with various glycolysis shRNAs. Cell viability was measured via MTT assay. Decreased cell viability in all TDP-43 WT and TDP-43 ΔNLS with various glycolysis <t>shRNA</t> (n = 3). Data were analyzed by one-way ANOVA followed by post hoc Tukey’s test. All data are mean ± SE
    Non Targeting Control Plko 1 Puro Plasmid Dna Ntc, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/plko%2E1+control+shrna/pLKO%2E1+Puro+NT+shRNA+(Plasmid+%23123302)/pmc12788653-276-28-38
    Average 93 stars, based on 1 article reviews
    non targeting control plko 1 puro plasmid dna ntc - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    96
    Addgene inc plko
    <t>Pathological</t> <t>TDP-43</t> elicits glycolytic impairment in cells. a , b Agilent seahorse glycolytic stress test was performed on n = 3 independent biological repeats. Glycolysis and Glycolytic Capacity were measured according to manufacturer’s protocol. ECAR values were normalized to total protein then plotted against time. Individual glycolysis and glycolytic capacity values were normalized to total protein level then to individual control from each biological repeat. a Stable HEK293 cells were overexpressed with either YFP (control), TDP-43 WT or TDP-43 ΔNLS . Data were analyzed by one-way ANOVA followed by post hoc Tukey’s test. b TDP-43 G298S patient iPSC and control iPSC were differentiated into motor neurons with our established protocol. On day 26 following differentiation, cells were treated with MG-132 (1 μM) for 24 h. Data were analyzed by Student’s t-test. c YFP (control), TDP-43 WT or TDP-43 ΔNLS stable cells were transiently transfected with various glycolysis shRNAs. Cell viability was measured via MTT assay. Decreased cell viability in all TDP-43 WT and TDP-43 ΔNLS with various glycolysis <t>shRNA</t> (n = 3). Data were analyzed by one-way ANOVA followed by post hoc Tukey’s test. All data are mean ± SE
    Plko, supplied by Addgene inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/plko%2E1+control+shrna/pLKO%2E1+-+TRC+control+(Plasmid+%2310879)/pm41412800-229-62-63
    Average 96 stars, based on 1 article reviews
    plko - by Bioz Stars, 2026-09
    96/100 stars
      Buy from Supplier

    95
    Addgene inc plko 1 control shrna vector targeting gfp
    <t>Pathological</t> <t>TDP-43</t> elicits glycolytic impairment in cells. a , b Agilent seahorse glycolytic stress test was performed on n = 3 independent biological repeats. Glycolysis and Glycolytic Capacity were measured according to manufacturer’s protocol. ECAR values were normalized to total protein then plotted against time. Individual glycolysis and glycolytic capacity values were normalized to total protein level then to individual control from each biological repeat. a Stable HEK293 cells were overexpressed with either YFP (control), TDP-43 WT or TDP-43 ΔNLS . Data were analyzed by one-way ANOVA followed by post hoc Tukey’s test. b TDP-43 G298S patient iPSC and control iPSC were differentiated into motor neurons with our established protocol. On day 26 following differentiation, cells were treated with MG-132 (1 μM) for 24 h. Data were analyzed by Student’s t-test. c YFP (control), TDP-43 WT or TDP-43 ΔNLS stable cells were transiently transfected with various glycolysis shRNAs. Cell viability was measured via MTT assay. Decreased cell viability in all TDP-43 WT and TDP-43 ΔNLS with various glycolysis <t>shRNA</t> (n = 3). Data were analyzed by one-way ANOVA followed by post hoc Tukey’s test. All data are mean ± SE
    Plko 1 Control Shrna Vector Targeting Gfp, supplied by Addgene inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/plko%2E1+control+shrna/pLKO%2E1+GFP+shRNA+(Plasmid+%2330323)/pmc12482338__10020_2025_1353_MOESM4_ESM-35-22-34
    Average 95 stars, based on 1 article reviews
    plko 1 control shrna vector targeting gfp - by Bioz Stars, 2026-09
    95/100 stars
      Buy from Supplier

    93
    Addgene inc plko 1 scrambled control shrna vector
    <t>Pathological</t> <t>TDP-43</t> elicits glycolytic impairment in cells. a , b Agilent seahorse glycolytic stress test was performed on n = 3 independent biological repeats. Glycolysis and Glycolytic Capacity were measured according to manufacturer’s protocol. ECAR values were normalized to total protein then plotted against time. Individual glycolysis and glycolytic capacity values were normalized to total protein level then to individual control from each biological repeat. a Stable HEK293 cells were overexpressed with either YFP (control), TDP-43 WT or TDP-43 ΔNLS . Data were analyzed by one-way ANOVA followed by post hoc Tukey’s test. b TDP-43 G298S patient iPSC and control iPSC were differentiated into motor neurons with our established protocol. On day 26 following differentiation, cells were treated with MG-132 (1 μM) for 24 h. Data were analyzed by Student’s t-test. c YFP (control), TDP-43 WT or TDP-43 ΔNLS stable cells were transiently transfected with various glycolysis shRNAs. Cell viability was measured via MTT assay. Decreased cell viability in all TDP-43 WT and TDP-43 ΔNLS with various glycolysis <t>shRNA</t> (n = 3). Data were analyzed by one-way ANOVA followed by post hoc Tukey’s test. All data are mean ± SE
    Plko 1 Scrambled Control Shrna Vector, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/plko%2E1+control+shrna/PLKO%2E1-Scrambled+(Plasmid+%23136035)/pm40921794-168-20-27
    Average 93 stars, based on 1 article reviews
    plko 1 scrambled control shrna vector - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    Image Search Results


    Pathological TDP-43 elicits glycolytic impairment in cells. a , b Agilent seahorse glycolytic stress test was performed on n = 3 independent biological repeats. Glycolysis and Glycolytic Capacity were measured according to manufacturer’s protocol. ECAR values were normalized to total protein then plotted against time. Individual glycolysis and glycolytic capacity values were normalized to total protein level then to individual control from each biological repeat. a Stable HEK293 cells were overexpressed with either YFP (control), TDP-43 WT or TDP-43 ΔNLS . Data were analyzed by one-way ANOVA followed by post hoc Tukey’s test. b TDP-43 G298S patient iPSC and control iPSC were differentiated into motor neurons with our established protocol. On day 26 following differentiation, cells were treated with MG-132 (1 μM) for 24 h. Data were analyzed by Student’s t-test. c YFP (control), TDP-43 WT or TDP-43 ΔNLS stable cells were transiently transfected with various glycolysis shRNAs. Cell viability was measured via MTT assay. Decreased cell viability in all TDP-43 WT and TDP-43 ΔNLS with various glycolysis shRNA (n = 3). Data were analyzed by one-way ANOVA followed by post hoc Tukey’s test. All data are mean ± SE

    Journal: Acta Neuropathologica

    Article Title: TDP-43 impairs glycolysis by sequestering hexokinase 1 in amyotrophic lateral sclerosis

    doi: 10.1007/s00401-026-02996-6

    Figure Lengend Snippet: Pathological TDP-43 elicits glycolytic impairment in cells. a , b Agilent seahorse glycolytic stress test was performed on n = 3 independent biological repeats. Glycolysis and Glycolytic Capacity were measured according to manufacturer’s protocol. ECAR values were normalized to total protein then plotted against time. Individual glycolysis and glycolytic capacity values were normalized to total protein level then to individual control from each biological repeat. a Stable HEK293 cells were overexpressed with either YFP (control), TDP-43 WT or TDP-43 ΔNLS . Data were analyzed by one-way ANOVA followed by post hoc Tukey’s test. b TDP-43 G298S patient iPSC and control iPSC were differentiated into motor neurons with our established protocol. On day 26 following differentiation, cells were treated with MG-132 (1 μM) for 24 h. Data were analyzed by Student’s t-test. c YFP (control), TDP-43 WT or TDP-43 ΔNLS stable cells were transiently transfected with various glycolysis shRNAs. Cell viability was measured via MTT assay. Decreased cell viability in all TDP-43 WT and TDP-43 ΔNLS with various glycolysis shRNA (n = 3). Data were analyzed by one-way ANOVA followed by post hoc Tukey’s test. All data are mean ± SE

    Article Snippet: The following constructs pcDNA3.2-YFP (addgene #84910), pcDNA3.2-TDP-43 WT -YFP (human) (addgene #84911), pcDNA3.2-TDP-43 ΔNLS -YFP (human) (addgene #84912), pLD-puro-Cc-TARDBP-A315T_VA Plasmid (human TDP-43 A315T) (addgene #141329), pLD-puro-Cc-TARDBP-WT_VA Plasmid (human TDP-43 WT) (addgene #141327), and shRNA control (addgene: #8453) were purchased from addgene.

    Techniques: Control, Transfection, MTT Assay, shRNA